Ultragenyx Pharmaceutical Inc. 4

EVP and Chief Legal Officer Karah Herdman Parschauer sold 1,900 shares of Ultragenyx Pharmaceutical Inc. common stock at $24.92 per share.

On August 3, 2026, Karah Herdman Parschauer, EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc., sold 1,900 shares of Ultragenyx common stock at an average price of $24.92 per share for total proceeds of approximately $47,348, leaving her with direct ownership of 92,562 shares, which includes previously reported shares underlying restricted stock units subject to vesting conditions.

Filing Facts

CIK

1515673

Ticker

RARE

Form

4

Source Type

fda

Accession

0001193125-26-332547

Alert Tier

5